TN constitutes task force for mucormycosis

The committee, which comprises 12 members including medical experts drawn from a number of specialities from government and private hospitals, would advise the government on prevention and treatment of the fungal disease

May 28, 2021 04:08 pm | Updated 04:08 pm IST - CHENNAI

Amphotericin B, the drug used in the treatment of mucormycosis. Photograph used for representational purposes only

Amphotericin B, the drug used in the treatment of mucormycosis. Photograph used for representational purposes only

A Task Force Committee chaired by the Director of Medical Education (DME) has been constituted to advise the State government on issues related to mucormycosis, the invasive fungal disease being reported in patients recovering from COVID-19.

The committee, which comprises 12 members including medical experts drawn from a number of specialities from government and private hospitals, would advise the government on prevention and treatment of mucormycosis and update it on the latest translational research on mucormycosis.

While the DME is the chairman of the committee, the director of Regional Institute of Ophthalmology and Government Ophthalmic Hospital is the member secretary. The directors of Medical and Rural Health Services and Public Health and Preventive Medicines are among the members of the committee.

ENT specialists Mohan Kameswaran of Madras ENT Research Foundation and Babu Manohar of Apollo Hospitals, infectious diseases specialists Subramanian Swaminathan of Global Hospital and V. Ramasubramanian of Apollo Hospitals, Mohan Rajan of Rajan Eye Care, microbiologists Anupama Nithya of Sri Ramachandra Hospital and Balajee of Global Hospital, the heads of ENT and Microbiology departments of Madras Medical College are the other members of the task force.

The State government on May 20 declared mucormycosis as a notified disease under the Tamil Nadu Public Health Act, 1939.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.